Total Payments
$3,057
2024 Payments
$482.67
Companies
30
Transactions
169
Medicare Patients
3,390
Medicare Billing
$427,846
Payment Breakdown by Category
Food & Beverage$2,295 (75.1%)
Education$762.42 (24.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,295 | 157 | 75.1% |
| Education | $762.42 | 12 | 24.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $639.07 | 28 | $0 (2024) |
| PFIZER INC. | $373.22 | 29 | $0 (2024) |
| Genentech USA, Inc. | $323.16 | 25 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $218.79 | 15 | $0 (2020) |
| Amgen Inc. | $184.75 | 6 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $116.11 | 6 | $0 (2024) |
| Kyowa Kirin, Inc. | $111.68 | 6 | $0 (2022) |
| Gilead Sciences, Inc. | $104.31 | 8 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $100.70 | 7 | $0 (2020) |
| Janssen Products, LP | $99.95 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $482.67 | 18 | Janssen Biotech, Inc. ($189.90) |
| 2023 | $56.93 | 3 | Regeneron Healthcare Solutions, Inc. ($21.98) |
| 2022 | $123.45 | 2 | Amgen Inc. ($99.95) |
| 2021 | $294.79 | 13 | Seagen Inc. ($99.95) |
| 2020 | $340.76 | 21 | Janssen Biotech, Inc. ($90.61) |
| 2019 | $794.17 | 47 | Genentech USA, Inc. ($161.55) |
| 2018 | $424.03 | 31 | Janssen Biotech, Inc. ($94.40) |
| 2017 | $540.65 | 34 | Janssen Products, LP ($99.95) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Oncology | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Education | In-kind items and services | $25.95 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Oncology | ||||||
| 11/08/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.49 | General |
| 09/30/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Oncology | ||||||
| 08/23/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $15.00 | General |
| Category: Rare Disease | ||||||
| 08/16/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Oncology | ||||||
| 08/14/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/09/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: HEMATOLOGY | ||||||
| 08/05/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 07/08/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Oncology | ||||||
| 07/05/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 06/11/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Education | In-kind items and services | $89.95 | General |
| Category: Oncology | ||||||
| 05/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Oncology | ||||||
| 01/18/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: ONCOLOGY | ||||||
| 07/06/2023 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug), PLUVICTO | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Oncology | ||||||
| 04/25/2023 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: BioOncology | ||||||
| 05/17/2022 | Kyowa Kirin, Inc. | POTELIGEO (Drug) | Education | In-kind items and services | $23.50 | General |
| Category: Monoclonal Antibody | ||||||
| 03/25/2022 | Amgen Inc. | — | Education | In-kind items and services | $99.95 | General |
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 05/17/2021 | GENZYME CORPORATION | ELITEK (Biological), SARCLISA | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 996 | 1,752 | $385,531 | $113,160 |
| 2022 | 7 | 799 | 1,556 | $338,859 | $98,150 |
| 2021 | 7 | 755 | 1,676 | $370,315 | $113,090 |
| 2020 | 7 | 840 | 1,988 | $375,534 | $103,446 |
Total Patients
3,390
Total Services
6,972
Medicare Billing
$427,846
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 298 | 659 | $160,084 | $46,587 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 326 | $79,218 | $19,408 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 187 | 276 | $47,386 | $13,251 | 28.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 53 | 89 | $17,444 | $7,925 | 45.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 106 | $14,522 | $6,321 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 113 | $19,436 | $4,462 | 23.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 58 | 68 | $13,056 | $4,253 | 32.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 30 | $7,770 | $2,942 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 26 | 26 | $8,268 | $2,569 | 31.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 18 | 18 | $7,578 | $2,363 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,088 | $1,306 | 25.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $4,631 | $1,249 | 27.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 14 | $1,050 | $524.44 | 49.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 223 | 595 | $144,466 | $40,411 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 237 | 387 | $66,509 | $17,773 | 26.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 85 | 204 | $49,572 | $14,039 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 91 | 154 | $26,488 | $7,376 | 27.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 38 | 65 | $12,740 | $5,038 | 39.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 32 | 32 | $13,460 | $4,328 | 32.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 33 | 58 | $7,946 | $3,129 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $10,167 | $3,091 | 30.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 28 | 29 | $7,511 | $2,965 | 39.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 233 | 729 | $178,005 | $52,693 | 29.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 201 | 357 | $61,311 | $17,666 | 28.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 86 | 218 | $53,250 | $15,704 | 29.5% |
About Dr. Scott Pierce, M.D
Dr. Scott Pierce, M.D is a Hematology & Oncology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376511444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Pierce, M.D has received a total of $3,057 in payments from pharmaceutical and medical device companies, with $482.67 received in 2024. These payments were reported across 169 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,295).
As a Medicare-enrolled provider, Pierce has provided services to 3,390 Medicare beneficiaries, totaling 6,972 services with total Medicare billing of $427,846. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Lexington, KY
- Active Since 03/14/2006
- Last Updated 06/24/2019
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1376511444
Products in Payments
- IMBRUVICA (Drug) $415.53
- DARZALEX (Biological) $223.54
- Alecensa (Biological) $140.08
- XTANDI (Drug) $103.00
- BENDEKA (Drug) $100.70
- ZYTIGA (Drug) $99.95
- Perjeta (Biological) $91.90
- SANCUSO (Drug) $88.18
- INLYTA (Drug) $81.97
- IBRANCE (Drug) $81.01
- EMPLICITI (Biological) $79.21
- MEKINIST (Drug) $67.12
- OPDIVO (Biological) $65.79
- SUTENT (Drug) $64.56
- KEYTRUDA (Biological) $51.77
- BOSULIF (Drug) $42.80
- XALKORI (Drug) $37.62
- SARCLISA (Biological) $36.11
- KISQALI (Drug) $33.77
- Neulasta (Biological) $32.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Lexington
Dr. Nicola Jabbour, M.d, M.D
Hematology & Oncology — Payments: $611,455
Hematology & Oncology $611,455
Dr. Lowell Anthony, M.d, M.D
Hematology & Oncology — Payments: $64,060
Hematology & Oncology $64,060
Dr. Zhonglin Hao, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $22,675
Hematology & Oncology $22,675
John Villano
Hematology & Oncology — Payments: $17,051
Hematology & Oncology $17,051
Dr. Jessica Croley, Md, MD
Hematology & Oncology — Payments: $13,189
Hematology & Oncology $13,189
Mr. Russell Eldridge, Md, MD
Hematology & Oncology — Payments: $10,781
Hematology & Oncology $10,781